Levetiracetam Noridem

Levetiracetam, the active ingredient in Levetiracetam Noridem, is an antiepileptic presented as an intravenous solution for intravenous use. It is prescribed to manage partial‑onset seizures, myoclonic seizures, and primary generalized tonic‑clonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and health‑care institutions worldwide. The company adheres to stringent quality standards and regulatory requirements across multiple markets.

Levetiracetam is an antiepileptic drug used to control various seizure types.

Partial‑onset seizures: reduces the frequency and severity of focal seizures. Myoclonic seizures: diminishes rapid, involuntary muscle jerks. Primary generalized tonic‑clonic seizures: helps prevent loss of consciousness and convulsive episodes.

Levetiracetam is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Fatigue - Dizziness - Somnolence - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Suicidal thoughts or behavior - Major depressive episodes - Blood dyscrasias (e.g., leukopenia, thrombocytopenia) - Anaphylaxis or severe hypersensitivity - Multi‑organ dysfunction syndrome

Levetiracetam requires careful consideration of patient‑specific factors before use. - Renal impairment: adjust dose based on creatinine clearance. - Hepatic impairment: monitor liver function tests. - Concomitant CNS depressants: observe for enhanced sedation. - Pregnancy: safety not established; weigh benefits against potential risks. - Mental health monitoring: watch for mood changes or suicidal ideation. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam may interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Alcohol: may increase central nervous system depression. - Enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin): may lower levetiracetam plasma levels.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs): monitor for mood alterations. - Immunosuppressants (e.g., tacrolimus): observe for possible concentration changes. - Renal excretion inhibitors (e.g., probenecid): may raise levetiracetam exposure.